Přihlásit se Zaregistrujte se zdarma

Cena / výnosy společnosti Agile Therapeutics Inc

Jaká je hodnota metriky Cena / výnosy společnosti Agile Therapeutics Inc?

Hodnota metriky Cena / výnosy společnosti Agile Therapeutics Inc je 1.20

Jaká je definice metriky Cena / výnosy?



Cena / výnosy (Price to sales ratio) je ukazatel,který představuje cenu společnosti ve srovnání s výškou její tržeb.

The price to sales ratio, Price/Sales ratio, P/S ratio, or PSR, is a valuation metric for stocks. It is calculated by dividing the company's market cap by the revenue in the most recent year. It can also be calculated by dividing the per-share stock price by per-share revenue. The price to sales ratio is for trailing twelve months so the reported sales are for the four previous quarters. Longer time periods can be examined at times.

A smaller price to sales ratio is usually thought to be a better investment since the investor is paying less for each unit of sales. However, sales do not reveal the whole picture, as the company may be unprofitable with a low P/S ratio. Because of the limitations, this ratio is usually used only for unprofitable companies, since they don't have a price to earnings ratio (P/E ratio). The metric can be used to determine the value of a stock relative to its past performance. It may also be used to determine relative valuation of a sector or the market as a whole.

Price to sales ratios vary greatly between sectors, so they are most useful in comparing similar stocks within a sector or sub-sector. Comparing P/S ratios carries the implicit assumption that all firms in the comparison have an identical capital structure.

Cena / výnosy společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností Agile Therapeutics Inc

Čemu se věnuje společnost Agile Therapeutics Inc?

agile therapeutics is a forward-thinking women's healthcare company dedicated to fulfilling the unmet health needs of today's women. our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. our lead product candidate, twirla®, (ethinyl estradiol and levonorgestrel transdermal system), also known as ag200-15, is a once-weekly prescription contraceptive patch that recently completed phase 3 trials. twirla is based on our proprietary transdermal patch technology, called skinfusion®, which is designed to provide advantages over currently available patches and is intended to optimize patch adhesion and patient wearability. for more information, please visit the company website at www.agiletherapeutics.com. connect with us on twitter at @agilether.

Firmy s metrikou cena / výnosy podobnou společnosti Agile Therapeutics Inc